Introduction {#S0001}
============

Osteoarthritis (OA) is the most prevalent form of arthritis in Japan and worldwide.[@CIT0001]--[@CIT0002] In Japan, knee-related OA is found in 43% of men and 62% of women 40 years and older, while shoulder OA affects 17% of patients.[@CIT0003],[@CIT0004] OA comprises an estimated 75% of arthritis cases; it is one of the 10 leading sources of disability globally and one of the main sources of disability in older age. OA affects over half of the population aged 65 years and older.[@CIT0005]

OA is caused by mechanical stress and inflammation on the joints resulting in a breakdown of joint cartilage and the underlying bone. Symptoms often include joint pain, swelling, and stiffness, which can further lead to physical limitations and disability, sleep disturbance, and fatigue. OA is not only associated with chronic pain and disability but it is also related to poor mental health, with depressive disorders and anxiety being common among patients with OA.[@CIT0011],[@CIT0014] Specifically, a systematic review showed that 20% of patients with OA experience depression or anxiety.[@CIT0011]--[@CIT0013] Because the weight-bearing joints (eg, knee, hip, or ankle) tend to be most affected, patients with OA may experience restrictions in their ability to perform daily activities, which is associated with depression.[@CIT0006]--[@CIT0008] The relationship between musculoskeletal pain and mental health has also been reported in recent studies from Japan in which more severe chronic lower back pain was associated with lower quality of life and greater health care resource use.[@CIT0009]--[@CIT0013] Overall, the connection between OA and mental health has important implications, as depression has been linked to greater pain sensitivity and poorer coping mechanisms, which can subsequently interfere with the ability to successfully manage OA symptoms.[@CIT0005],[@CIT0015],[@CIT0016]

OA has been identified as a leading source of pain and disability in Japan.[@CIT0013] The association between depression and OA and the negative effect of depression on a patient's ability to successfully cope with OA have been well established. However, there is a scarcity of literature on patients with OA in Japan who also experience depression. We hypothesize that in Japan, the incremental effects of depression on patients with OA are represented in the increased health-related burden. This objective was accomplished by documenting differences in patient characteristics, health-related quality of life (HRQoL), and healthcare resource use between patients with OA by the presence of depressive symptoms.

Methods {#S0002}
=======

Sample {#S0002-S2001}
------

For this retrospective observational study, data were collected from the 2014 Japan National Health and Wellness Survey (Kantar Health, New York, USA) as reported previously.[@CIT0009],[@CIT0017] NHWS respondents were recruited through voluntary survey panels, with sampling stratified by gender and age to reflect the demographic distribution of the Japanese general adult population, as reported in the US Census International Database.[@CIT0018] The 2014 Japan NHWS was reviewed and exempted by Pearl Institutional Review Board (IRB) (Indianapolis, IN, USA; study number 14-KAN-106) on December 1, 2014. The IRB determined this study met the exemption requirements under 45CFR46.101(b)(2). Potential respondents for the NHWS were identified through the Lightspeed Research general panel. A convenience sample was used with an attempt to approximate the age and sex distribution of the adult population in Japan. All respondents who completed the online informed consent form were eligible to complete the survey. No ethical review was undertaken specifically to the analysis of the anonymous data presented in this report. All data were self-reported and missing data were reported as "declined to answer". For example, previous studies have shown that the NHWS Japan data are similar in demographic composition to the Japan adult population and that disease-related characteristics for OA and for other conditions were similarly distributed.[@CIT0019]--[@CIT0021] Of the total NHWS sample (N=30,000), 565 respondents reported receiving an OA diagnosis from a physician and were included in the current study.

Measures {#S0002-S2002}
--------

### Depression symptoms {#S0002-S2002-S3001}

Depression symptoms were measured using the Patient Health Questionnaire (PHQ-9),[@CIT0022] a validated scale for classifying the severity of depressive symptoms over the last 2weeks. According to the PHQ-9, depression symptom severity is categorized as scores of 0--4=none, 5--9=mild, 10--14=moderate, 15--19=moderately severe, and 20--27=severe. The scale evaluates the frequency of anhedonia, depressed mood, sleep disturbance, lack of energy, appetite disturbance, negative self-feelings, difficulty concentrating, psychomotor retardation or agitation, and thoughts of self-harm. A single-item measure of the interference of these symptoms was also included. For this study, respondents who scored ≥10 (the cutoff associated with symptoms of moderate depression) were considered to have exhibited depressive symptoms, regardless of whether they indicated a diagnosis of depression, and respondents scoring \<10 (associated with minimal or mild depression symptoms) were considered not to have symptoms of depression; this value has shown good sensitivity and specificity for major depression in previous research.[@CIT0022]

### Demographic characteristics {#S0002-S2002-S3002}

The demographic characteristics assessed included age, gender, marital status (married or living with a partner vs other), employment status (full/part-time vs not employed/disabled/retired/student/homemaker), annual household income (\<¥3 million, ¥3--\<¥5 million, ¥5--\<¥8 million, ≥¥8 million, or decline to answer), and level of education (completed 4-year university degree vs less than university degree).

### Health-related characteristics {#S0002-S2002-S3003}

Health-related characteristics that were assessed included body mass index (calculated from height and weight), cigarette smoking (never or former vs current), alcohol use (any vs no alcohol), and vigorous exercise in the past month (yes vs no). Charlson Comorbidity Index (CCI) scores were also included. The CCI is a summary weighted index of the presence of the following conditions: HIV/AIDS, metastatic tumor, moderate or severe liver disease, lymphoma, leukemia, any tumor, moderate/severe renal disease, hemiplegia, diabetes, mild liver disease, ulcer disease, connective tissue disease, chronic pulmonary disease, dementia, cerebrovascular disease, peripheral vascular disease, myocardial infarction, congestive heart failure, and diabetes with end organ damage.[@CIT0023] The greater the total index score, the greater the comorbid burden on the patient. CCI was used in this study as a categorical variable (0, 1, 2+).

### OA-related characteristics {#S0002-S2002-S3004}

Measures of OA-related characteristics included self-reported length of diagnosis (in years), number of joints affected, severity of arthritis (mild, moderate, or severe), frequency of problems with arthritis (daily, 4--6 times a week, 2--3 times a week, once a week, 2--3 times a month, or once a month or less often), and use of prescription medication for arthritis (yes vs no).[@CIT0017]

### Health-related quality of life {#S0002-S2002-S3005}

HRQoL was assessed with the revised validated Medical Outcomes Study 36-Item Short Form Health Survey version 2 (SF-36v2). The instrument contains 36 questions and measures eight health concepts (physical functioning, role physical, bodily pain, general health, vitality, social functioning, role emotional, and mental health), according to Japanese-based population norms (mean=50, SD=10). Mental component summary and physical component summaryscores with US-based norms (mean=50, SD=10) were also used. In addition, the SF-36v2 instrument was used to generate a single index of health state utilities, namely the Short-Form 6-Dimension (SF-6D).[@CIT0024] Scoring of the SF-6D takes into consideration six dimension of the SF-36, including physical functioning, role participation, social functioning, bodily pain, mental health, and vitality. It is scored. The SF-6D index has interval scoring properties and yields summary scores from 0.0 (worst health state) to 1.0 (best health state) with an empirical floor of 0.3. Higher scores on these measures indicate better HRQoL.

### Work productivity and activity impairment {#S0002-S2002-S3006}

Work productivity and activity impairment was measured using the validated Work Productivity and Activity Impairment-General Health questionnaire,[@CIT0025] which measures four domains: 1) absenteeism (the percentage of work time missed within the past week due to one's health), 2) presenteeism (the percentage of impairment at work within the past week due to one's health), 3) overall work productivity loss (an overall impairment estimate that assesses a combination of absenteeism and presenteeism), and 4) activity impairment (the percentage of impairment in day-to-day activities within the past week due to one's health). Higher percentage scores indicate greater impairment. Only employed participants provided data for absenteeism, presenteeism, and overall work productivity impairment, whereas the full sample of patients with OA completed the activity impairment measure.

### Health care resource use {#S0002-S2002-S3007}

Health care resource use was measured using self-reported number of total physician visits, emergency room (ER) visits, number of ER visits, and the number of times respondents were hospitalized in the past six months.

Analyses {#S0002-S2003}
--------

Respondents with OA and moderate to severe depression symptoms (PHQ-9 score ≥10) were compared to respondents with physician-diagnosed OA and mild or no depression symptoms using chi-square tests for categorical variables and independent-samples t-tests for continuous variables. Multivariable models analyzed health outcomes as a function of depression symptoms (reference=none/mild depression vs depression=moderate/severe). These models were used to demonstrate the burden of depression symptoms on patients with physician-diagnosed OA, controlling for socio-demographic or health-related variables that varied by group at *p*\<0.05 in the bivariate analyses: age, marital status, employment status, and smoking status. Regression models were chosen according to the distribution of the outcome variable as tested using the one-sample Kolmogorov--Smirnov test for normality and for non-linear outcomes using the likelihood ratio test in the regression model to assess over-dispersion (Poisson vs negative binomial). Thus, generalized linear regression models were used for measures with normal (HRQoL and work productivity outcomes) or negative binomial (health care resource utilization) distributions. Linear model assumptions were tested for linearity of covariates and disproportionate influential observations using Cook's distance and studentized residuals. All analyses assumed a null hypothesis, with a two-sided α\<0.05, and were conducted with IBM Statistical Package for the Social Sciences (SPSS) Statistics, version 22 or later.

Results {#S0003}
=======

Our final sample comprises a total of N=565 respondents with OA, and 63 (11%) of these individuals had moderate or severe depression symptoms, as measured by the PHQ-9 (score ≥10). These individuals were considerably younger than those without depression symptoms, more likely to be employed, less likely to be married or living with a partner, had higher CCI scores, and were more often current smokers, although gender and OA-related characteristics did not differ significantly between patients with and without depression symptoms ([Table 1](#T0001){ref-type="table"}). Table 1Respondent characteristics for patients with OA with and without depressionTotal\
(N=565)No or mild depression (N=502)Moderate or severe depression\
(N=63)%/Meann/SD%/Meann/SD%/Meann/SD*p*-valueAge, mean (SD) years59.1 (12.1)60.6 (11.0)47.0 (13.7)\<0.001 \<40 years8.8%506.4%3228.6%18\<0.001 40--49 years8.3%476.0%3027.0%17 50--59 years24.6%13924.7%12423.8%15 60--69 years45.1%25548.4%24319.0%12 70+ years13.1%7414.5%731.6%1Female58.6%33158.6%29458.7%370.980Married or living with partner73.3%41474.9%37660.3%380.014Employed full or part-time45.3%25643.2%21761.9%390.005Annual household income0.300 \<¥3 million18.4%10417.5%8825.4%16 ¥3 million to \<¥5 million27.6%15627.5%13828.6%18 ¥5 million to \<¥9 million29.7%16831.1%15619.0%12 ¥9 million or more13.8%7813.5%6815.9%10 Decline to answer10.4%5910.4%5211.1%7Completed 4-year university degree43.5%24642.6%21450.8%320.218CCI0.053 069.9%39570.5%35465.1%41 120.9%11821.3%10717.5%11 2+9.2%528.2%4117.4%11BMI categories in kg/m^2^0.157 Underweight (\<18.5)7.6%437.2%3611.1%7 Normal (18.5--24.9)63.4%35865.1%32749.2%31 Overweight (25--29.9)21.8%12320.7%10430.2%19 Obese (≥30)4.4%254.4%224.8%3 Decline to answer2.8%162.6%134.8%3Smoking status0.012 Current smoker17.3%9815.7%7930.2%19 Former smoker31.3%17732.5%16322.2%14Never smoker51.3%29051.8%26047.6%30Drinks alcohol67.4%38166.1%33277.8%490.063Vigorous exercise in past month49.7%28150.4%25344.4%280.373Length of arthritis diagnosis, mean (SD) years9.5 (11.8)9.7 (12.1)7.6 (8.9)0.221Number of joints affected, mean (SD)1.8 (1.6)1.8 (1.5)2.0 (2.1)0.239Severity of arthritis (self-reported)0.514 Mild50.1%28350.4%25347.6%30 Moderate38.4%21738.6%19436.5%23 Severe11.5%6511.0%5515.9%10Frequency of problems with arthritis0.406 Daily36.3%20536.3%18236.5%23 4--6 times a week8.1%468.2%417.9%5 2--3 times a week12.2%6911.6%5817.5%11 Once a week4.4%254.0%207.9%5 2--3 times a month11.0%6211.2%569.5%6 Once a month or less often28.0%15828.9%14520.6%13Use a prescription for OA30.8%17429.7%14939.7%250.105[^1]

Depression symptoms were associated with substantial decrements in HRQoL ([Table 2](#T0002){ref-type="table"}), particularly on the MCS (nearly 20 points) and SF-6D (over 0.15 points). Substantial and significant decrements on all other SF-36v2 metrics, including physically oriented metrics, such as PCS, physical functioning, and bodily pain, were also observed. Table 2Health-related quality of life for patients with OA with and without depression^a^Total\
(N=565)No or mild depression\
(N=502)Moderate or severe depression\
(N=63)Mean(SD)Mean(SD)Mean(SD)*p*-valueMCS47.6(10.7)49.7(8.7)30.7(10.6)\<0.001PCS46.9(7.8)47.4(7.4)42.6(9.7)\<0.001SF-6D0.69(0.12)0.71(0.11)0.54(0.11)\<0.001Physical functioning42.8(15.9)43.9(14.4)33.3(22.6)\<0.001Physical role limitations43.3(13.7)44.9(12.4)30.4(16.7)\<0.001Bodily pain42.9(10.2)43.9(9.5)34.9(11.7)\<0.001General health42.4(10.8)43.8(9.9)30.9(10.7)\<0.001Vitality45.3(11.0)47.1(9.8)31.1(10.4)\<0.001Social functioning45.6(12.9)47.6(11.2)29.4(14.7)\<0.001Emotional role limitations46.0(12.6)47.7(10.9)31.7(15.6)\<0.001Mental health47.8(11.1)50.0(9.0)30.3(10.9)\<0.001[^2][^3]

Among employed respondents, moderate to severe depression symptoms were associated with markedly higher work productivity impairment, except for absenteeism ([Table 3](#T0003){ref-type="table"}). For patients with moderate to severe depression symptoms, both presenteeism and overall work impairment were approximately double the levels reported by their counterparts with no or mild depression symptoms. Activity impairment was also nearly double for those with moderate to severe depression symptoms, relative to the group with no or mild depression symptoms. Moderate to severe depression symptoms were associated with a greater number of physician visits, ER visits, and hospitalizations for patients with OA, compared with no or mild depression symptoms ([Table 3](#T0003){ref-type="table"}). Table 3Work productivity and activity impairment and health care resource use for patients with OA with and without depressionTotal\
(N=565)No or mild depression\
(N=502)Moderate or severe depression\
(N=63)MeanSDMeanSDMeanSD*p*-valueWork productivity and activity impairment^a^ Absenteeism (%)**^b^**3.815.83.515.45.517.60.472 Presenteeism (%)**^c^**27.026.822.924.351.527.9\<0.001 Overall work impairment (%)**^b^**29.229.024.827.053.628.3\<0.001 Activity impairment (%)32.528.829.627.356.229.3\<0.001Health care resource utilization^d^ Physician visits11.916.410.713.621.329.5\<0.001  (median, IQR)(7)(3--14)(12)(5--23)0.001 ^e^ ER visits0.64.90.32.13.013.4\<0.001  (median, IQR)(0)(0--0)(0)(0--0)0.182 ^e^ Hospitalizations1.67.41.35.64.315.70.002  (median, IQR)(0)(0--0)(0)(0--0)0.082 ^e^[^4][^5]

After adjusting for potential confounders, HRQoL remained significantly lower among respondents with moderate to severe depression symptoms, compared with those with no or mild depression symptoms ([Table 4](#T0004){ref-type="table"}). Additionally, impairments to work productivity (presenteeism and overall work impairment) and daily activities, as well as health care resource utilization (physician visits, ER visits, and hospitalizations), were significantly higher among respondents with moderate to severe (vs mild or no) depression symptoms. For absenteeism, no statistically significant differences were observed ([Table 4](#T0004){ref-type="table"}). Table 4Adjusted means of health outcomes for patients with OA with and without depressionNo or mild depressionModerate or severe depressionMean(SE)Mean(SE)*p*-valueHRQoL(N=502)(N=63) MCS48.94(0.48)31.72(1.20)\<0.001 PCS46.94(0.42)41.93(1.04)\<0.001 SF-6D0.71(0.01)0.54(0.02)\<0.001 Physical functioning43.14(0.84)32.10(2.08)\<0.001 Physical role limitations44.46(0.71)30.08(1.75)\<0.001 Bodily pain43.33(0.53)35.01(1.32)\<0.001 General health42.55(0.54)30.12(1.33)\<0.001 Vitality46.21(0.53)32.08(1.31)\<0.001 Social functioning46.76(0.63)29.79(1.56)\<0.001 Emotional role limitations47.17(0.63)31.84(1.55)\<0.001 Mental health49.14(0.49)31.25(1.22)\<0.001Work productivity and activity impairment (%)(N=194)(N=35) Absenteeism3.71(1.24)5.15(2.79)0.639 Presenteeism23.14(1.90)50.55(4.45)\<0.001 Overall work impairment25.01(2.14)52.71(4.81)\<0.001(N=502)(N=63) Activity impairment30.65(1.49)56.98(3.70)\<0.001Healthcare resource utilization(N=502)(N=63) Physician visits11.79(0.68)21.69(3.10)\<0.001 ER visits0.31(0.03)3.12(0.52)\<0.001 Hospitalizations1.39(0.10)5.15(0.88)\<0.001[^6][^7]

Discussion {#S0004}
==========

Approximately 11% of respondents with OA in our study had symptoms of moderate to severe depression, according to the PHQ-9. Our results showed that depression symptoms are more severe among patients with OA who smoke and are not married or living with a partner. The frequency of moderate to severe depression among employed patients with OA was greater than among the unemployed. The reason could be that the age of patients with symptoms of moderate to severe depression was, on average, lower than that of patients with no or mild depression symptoms, and patients under age 60 had a higher frequency of employment. Gender was not differentially associated with depression severity in OA, which may be due to cultural factors and may also warrant further investigation in a future study.

The prevalence of moderate to severe depression symptoms reported by the current study is lower than the estimates reported in US-based studies investigating OA and depression.[@CIT0016],[@CIT0026] This 11% prevalence of depression may reflect a slight skew toward a younger healthier population in the NHWS in general.[@CIT0027] Cultural factors may play a role, as depression is less prevalent in Japan than in Western countries.[@CIT0028] Results were consistent with other research that identified characteristics, such as smoking,[@CIT0029],[@CIT0030] living alone,[@CIT0016] and widowed or divorced status,[@CIT0029] as being associated with depression. However, it is unclear whether these characteristics are causal factors for depression in the adult population with OA, and further research is needed to clarify this issue.

Respondents with OA who had symptoms of moderate to severe depression had worse mental and physical HRQoL, including more interference from bodily pain, than those with no or mild depression symptoms, even after adjusting for potential confounders. Studies show the interconnectedness between physical pain and mental health.[@CIT0005],[@CIT0016],[@CIT0031]--[@CIT0034] While depression and anxiety are associated with reduced activity leading to chronic pain, functional disability has been reported to be a risk factor for depression, both pathways impacting prognosis and rehabilitation.[@CIT0031]--[@CIT0034]

The literature has produced conflicting results as to whether the relationship between depression and pain or disability varies by gender.[@CIT0009],[@CIT0015],[@CIT0031] Specifically, some studies have reported significant gender differences in depression among those with OA, with women reporting higher rates of depression than men.[@CIT0015] In contrast, the findings that reported no significant gender difference in the prevalence of depression severity in participants with OA are aligned with other studies.[@CIT0015],[@CIT0031]

Greater impairments to work productivity and daily activities among those with than without depression symptoms were reported by a previous study of patients with chronic lower back pain in Japan,[@CIT0009] which is similar to the results of the current study. Moreover, consistent with the present study, a prior retrospective observational study of 167,068 US patients with arthritis demonstrated that those with (vs without) comorbid depression had greater disability and limitations to work and social activities, as well as poorer general health and HRQoL.[@CIT0035] Therefore, the collective evidence suggests that depression symptoms may substantially augment the burden of OA.

In the present findings, absenteeism and depression symptoms were not significantly associated with each other, which was aligned with prior research showing Japanese workers tend to have fewer sick leave claims than workers in other countries.[@CIT0036] Prior research has also reported that health care expenditures were 39% higher among adults with OA who also reported depression, when compared with individuals with OA who did not have depression;[@CIT0026] this is in accordance with the patterns of health care resource use found in the present study. One possible explanation is that patients with both chronic physical and psychological conditions may use the healthcare system more often than individuals who solely have physical impairments.[@CIT0026] For example, patients with OA who also have symptoms of moderate to severe depression may visit both psychiatric and orthopedic health care providers; alternatively, these patients may perceive their health to be worse, relative to the health perceptions of patients without depression.[@CIT0026]

Overall, this study contributes to the literature by identifying key differences between respondents with OA who have symptoms of moderate to severe depression and counterparts with no or mild depression symptoms. Notably, this is one of the first studies to explore these relationships among patients with OA in Japan. The observed association between moderate to severe depression symptoms and health-related burden among patients with OA suggests that physicians should screen for and address symptoms of depression when treating OA, particularly for individuals who may be at a greater risk of developing depression. In the workplace, for example, those with presenteeism may be at greater risk of depression, although this may not be the case among those with absenteeism. Mitigating the impact of depression symptoms is essential, as prior research indicates that depression can interfere with the effective management of OA by reducing patients' adherence to their medication regimen.[@CIT0037] Critical aspects of integrated programs that address both depression and OA include screening for depression and pain at the first visit and follow-up, supporting patient self-efficacy through education and behavioral therapy, and adjusting treatment intensity, based on a patient's progress. The results of the current study can help to inform clinicians about the importance of identifying and treating patients with OA who are also likely to concurrently have depression.

The cross-sectional study design prevents us from detecting causal or longitudinal relationships between variables. The measures in the study were self-reported, and respondent recall bias may have introduced measurement error into the study findings. We also cannot exclude the possibility that unmeasured variables could at least partially explain the results, such as clinical measures of severity. The data were collected using an Internet survey of respondents who opted to participate. Therefore, selection bias may have affected the representativeness of the study population and prevalence of OA. Specifically, it is possible that younger adults are more likely to participate in Internet surveys like the NHWS, which could account for the unexpectedly low prevalence of OA in the overall NHWS sample. In general, OA knee prevalence, for example, is highest among older adults ages 70 years and older, and this age group represents approximately 14% of the study sample.[@CIT0003],[@CIT0004],[@CIT0038] Moreover, given the relatively young age of patients with physician-diagnosed OA in this study, the findings may underestimate both the burden of OA and the incremental impact of depression on this burden.

Conclusion {#S0005}
==========

In this study, over 10% of patients with physician-diagnosed OA reported symptoms of moderate to severe depression. There were significant differences in HRQoL, work productivity impairment, and health care resource utilization between those with and without moderate to severe depression, even after adjusting for potential confounders. Hence, results suggest that depression may incrementally increase the health-related burden of OA. To help mitigate this burden, physicians should address symptoms of depression when treating patients with OA.
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[^1]: **Abbreviations:** BMI, body mass index; CC, Charlson Comorbidity Index; OA, osteoarthritis; SD, standard deviation.

[^2]: **Notes:** ^a^Data are from the self-reported patient survey responses to the Medical Outcomes Study 36-Item Short Form Health Survey version 2 (SF-36v2).  Component scores, MCS and PCS, as well as domain scores range from 0-100, with a mean=50 and standard deviation=10, with higher scores indicating better quality of life. The SF-6D is a health utility score ranging from 0.0 (worst health state) to 1.0 (best health state).

[^3]: **Abbreviations:** MCS, Mental Component Summary; PCS, Physical Component Summary; SD, standard deviation; SF-6D, Short-Form 6-Dimensions.

[^4]: **Notes:** ^a^The work and activity impairment scale is a patient-reported outcomes questionnaire that examines used to examine work and activity-related impairment in the past week due to one\'s health. Higher percentage scores indicates greater impairment; ^b^Among employed respondents only: total=229; no/mild=194; moderate/severe=35); ^c^Among employed respondents only: total=233; no/mild=199; moderate/severe=34); ^d^Self-reported total number of healthcare visits or hospitalization days for all health-related issues in the past 6 months was examined for all respondents; ^e^Mann-Whitney U test of difference in median values.

[^5]: **Abbreviations:** ER, emergency room; HCP, healthcare provider; IQR, interquartile range; SD, standard deviation.

[^6]: **Notes:** ^a^Generalized linear regression models were used for measures with normal distributions (HRQoL and work productivity outcomes) and negative binomial models were run for non-negative count data (healthcare resource utilization). All models were adjusted for age, marital status, employment status, and smoking status that were significant predictors of depression severity at *p*\<0.05 in the bivariate comparisons. Adjusted mean values and standard errors for each outcome are presented at the mean the group variable (none/mild or moderate/severe depression) controlling for each of the covariates. Differences between group mean values (i.e., differences in the indicator variable in the regression model) are indicated using the *p*-value.

[^7]: **Abbreviations:** ER, emergency room; HRQoL, health-related quality of life; MCS, Mental Component Summary; PCS, Physical Component Summary; SE, standard error; SF-6D, Short-Form 6-Dimensions.
